Is Vertex Pharmaceuticals Stock a Buy Now?

·3 min read
Is Vertex Pharmaceuticals Stock a Buy Now?

Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) spiked recently in response to good news for an experimental new drug. Successful results from a clinical trial with a drug that isn't part of the company's successful cystic fibrosis franchise are generating a lot of stock market buzz for Vertex Pharmaceuticals again. On Dec. 1, 2021, Vertex Pharmaceuticals' stock jumped after the company posted results from a human proof-of-concept study with VX-147.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting